BackExcelFin Acquisition Overview

ExcelFin Acquisition Total Liabilities

ExcelFin Acquisition's total liabilities is $15M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$15.01M
↓ 2.06% YoYΔ $-315974.00 vs prior year quarter

Peer average

Loading

ExcelFin Acquisition Total Liabilities History

Loading

ExcelFin Acquisition vs. peers: Total Liabilities Comparison

Loading

ExcelFin Acquisition Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

ExcelFin Acquisition (XFIN) FAQ

The latest total liabilities for XFIN is $15M as of June 2024. That compares with $15M in the prior-year period — down 2.1% year over year. Investors often review this figure alongside ExcelFin Acquisition's historical trend and sector peers before judging valuation or financial health.

Over the past year, XFIN's total liabilities moved from $15M to $15M — a 2.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in ExcelFin Acquisition's operating scale or balance-sheet position.

A total liabilities figure of $15M for XFIN is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting XFIN's total liabilities ($15M), review year-over-year change from $15M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.